MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,193,125 | -29.9% | 290,298 | 0.0% | 0.04% | -36.9% |
| Q4 2022 | $1,701,146 | -13.3% | 290,298 | 0.0% | 0.06% | -20.7% |
| Q3 2022 | $1,962,000 | -14.3% | 290,298 | -41.4% | 0.08% | -5.7% |
| Q2 2022 | $2,289,000 | +15.8% | 495,481 | 0.0% | 0.09% | +42.6% |
| Q1 2022 | $1,977,000 | -35.9% | 495,481 | 0.0% | 0.06% | -29.1% |
| Q4 2021 | $3,082,000 | +194.6% | 495,481 | +346.8% | 0.09% | +196.6% |
| Q3 2021 | $1,046,000 | -30.5% | 110,906 | 0.0% | 0.03% | -17.1% |
| Q2 2021 | $1,506,000 | -16.1% | 110,906 | 0.0% | 0.04% | -12.5% |
| Q1 2021 | $1,794,000 | -39.2% | 110,906 | 0.0% | 0.04% | -41.2% |
| Q4 2020 | $2,951,000 | +42.9% | 110,906 | 0.0% | 0.07% | +33.3% |
| Q3 2020 | $2,065,000 | -20.4% | 110,906 | 0.0% | 0.05% | -13.6% |
| Q2 2020 | $2,595,000 | – | 110,906 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |